Great Point Partners’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Great Point Partners's BLTE Position: Q3 2026 in Review
Great Point Partners opened a new position in Belite Bio (BLTE) in Q3 2026: 75,000 shares worth $12.7M. The stake represents 3.04% of the portfolio and ranks #14 among its holdings.
96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Great Point Partners held 75,000 shares of Belite Bio worth $12.7M as of Q3 2026.
- Belite Bio was a new Great Point Partners position in Q3 2026.
- Belite Bio made up 3.04% of Great Point Partners's portfolio in Q3 2026, its #14 holding.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Great Point Partners's 13F filing for Q3 2026, filed 16 Nov 2026.